1. D. S. Vasil’ev, N. L. Tumanova, I. A. Zhuravin, et al., “Morphofunctional changes in rat hippocampal field CA1 using pentylenetetrazole and lithium-pilocarpine models of convulsive states,” Zh. Evolyuts. Biokhim. Fiziol., 50, No. 6, 463–469 (2014).
2. D. S. Vasil’ev, N. L. Tumanova, V. V. Lavrent’eva, et al., “Ability of NMDA-type glutamate receptor blockers to prevent the development of pentylenetetrazole kindling and morphological changes in pyramidal neurons in the mouse hippocampus,” Ros. Fiziol. Zh., 99, No. 9, 1023–1034 (2013).
3. A. V. Zaitsev, “Classification and function of GABAergic interneurons in the mammalian neocortex,” Biol. Membrany, 30, No. 4, 253–270 (2013).
4. M. Alvarez-Dorado, M. E. Calcagnotto, K. M. Karkar, et al., “Cortical inhibition modified by embryonic neural precursors grafted into the postnatal brain,” J. Neurosci., 26, No. 28, 7380–7389 (2006).
5. V. Andre, C. Marescauz, A. Nehlig, and J. M. Fritschy, “Alterations of hippocampal GABAergic system contribute to development of spontaneous recurrent seizures in the rat lithium-pilocarpine model of temporal lobe epilepsy,” Hippocampus, 11, No. 4, 452–68 (2001).